NDV-4

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameNDV-4

Drug Alias Namerecombinant listeria monocytogenes vaccine expressing als3 (Novadigm)NDV-4

ClassificationVaccines > Development/production technology > Live attenuated vaccineVaccines > Development/production technology > Inactivated vaccine > Subunit vaccineBiologics > Protein drugs > Recombinant protein +[4]

Mechanisms of ActionImmunomodulators

TargetsNot applicable

Therapy Area/IndicationsCandidiasisStaphylococcal Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesHarbor-UCLA Research and Education Institute

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesNovadigm Therapeutics Inc

Active IndicationsN/A

Inactive IndicationsCandidiasisStaphylococcal Infections

Other Information

ATC CodeN/A